Subscribe to RSS
DOI: 10.1055/s-2003-38647
Sporadic Adenomas in Chronic Ulcerative Colitis
Sporadische Adenome bei Kolitis ulzerosaPublication History
Manuscript received: 3 June 2002
Accepted after revision: 12 August 2002
Publication Date:
15 April 2003 (online)

Zusammenfassung
Die Diagnose intraepithelialer Neoplasien und im Besonderen polypöser Neoplasien bei Patienten mit chronischer Colitis ulcerosa ist mit einem großen Risiko eines assoziierten invasiven Karzinoms verbunden. Histologisch können polypöse intraepitheliale Neoplasien nur schwierig von sporadischen Adenomen unterschieden werden, die auch bei Patienten mit Colitis ulcerosa auftreten können. Die Diagnose polypöser intraepithelialer Neoplasien bei Patienten mit Colitis ulcerosa führt, zumindest in manchen Zentren, zur Kolektomie, während sporadische Adenome mit einer Polypektomie ausreichend behandelt sind. Mit der Einführung neuer Techniken wurde in den letzten Jahren damit begonnen, die immunhistochemischen, vor allem aber die genetischen Unterschiede von Adenomen und kolitisassoziierten polypösen intraepithelialen Neoplasien zu charakterisieren.
Abstract
Presence of polyps with intraepithelial neoplasia in patients with ulcerative colitis (UC) is associated with a very high risk of associated invasive carcinoma. Histologically, these lesions may not easily be differentiated from sporadic adenomas, which may occur in patients with UC. The treatment option for patients with polyps with intraepithelial neoplasia includes, at least in some centres, total colectomy which contrasts to polypectomy for patients with sporadic adenomas. Until recently, adenomatous polyps were not diagnosed in patients with UC because of the inability to differentiate adequately between UC-associated dysplastic polyps and adenomas. Multiple attempts have been made over the years to differentiate between UC-associated polyps with intraepithelial neoplasia and sporadic adenomas in patients with UC to ensure adequate treatment and follow-up for the correct diagnosis. These studies include morphologic, immunohistochemical and genetic analysis of lesions considered to be representative for each entity.
Schlüsselwörter
Kolitis ulzerosa - Dyplasie - Adenome
Key words
Ulcerative colitis - intraepithelial neoplasia - adenoma
References
- 1 Schneider A. Stolte M. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Zeitschrift fur Gastroenterologie. 1993; 31 653-656
- 2 Suzuki K, Muto T, Shinozaki M. et al . Differential diagnosis of dysplasia-associated lesion or mass and coincidental adenoma in ulcerative colitis. Diseases of the Colon & Rectum. 1998; 41 322-327
- 3 Torres C, Antonioli D, Odze R D. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. American Journal of Surgical Pathology. 1998; 22 275-284
- 4 Medlicott S A, Jewell L D, Price L. et al . Conservative management of small adenomata in ulcerative colitis. American Journal of Gastroenterology. 1997; 92 2094-2098
- 5 Engelsgjerd M, Farraye F A, Odze R D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999; 117 1288-1294
- 6 Rubin P H, Friedman S, Harpaz N. et al . Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999; 117 1295-1300
- 7 Shiff S J, Rigas B. Colon adenomatous polyps - do they grow inward?. Lancet. 1997; 349 1853-1854
- 8 Andersen S N, Rognum T O, Bakka A. et al . Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. Molecular Pathology. 1998; 51 327-332
- 9 Fogt F, Poremba C, Shibao K. et al . Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis. Appl Immunohistochem Molecul Morphol. 2001; 9 143-149
- 10 Mueller E, Vieth M, Stolte M. et al . The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Human Pathology. 1999; 30 898-905
- 11 Walsh S V, Loda M, Torres C M. et al . P53 and beta catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. American Journal of Surgical Pathology. 1999; 23 963-969
- 12 Tarmin L, Yin J, Harpaz N. et al . Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Research. 1995; 55 2035-2038
- 13 Fogt F, Vortmeyer A O, Goldman H. et al . Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma. Hum Pathol. 1998; 9 131-136
- 14 Fogt F, Urbanski S J, Sanders M E. et al . Distinction between dysplasia associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis. Human Pathology. 2000; 31 288-291
- 15 Odze R D, Brown C A, Hartmann C J. et al . genetic alterations in chronic ulcerative colitis associated adenoma like DALMs are similar to non colitic sporadic adenomas. Am J Surg Pathol. 2000; 24 1209-1216
- 16 Mueller E, Vieth M, Stolte M. et al . The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Hum Pathol. 1999; 30 898-905
Franz Fogt MD, MRCPath, MBA
Associate Professor, Pathology and Laboratory Medicine, University of Pennsylvania, Presbyterian Medical Center
39th and Market Streets
Philadelphia, PA 19104
USA